Login

Balance sheets

In millions of USD, except per-share amounts
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets:
Cash
Prepaid expenses
Cash held in Trust Account for redemptions
Total current assets
Deferred offering costs
Prepaid insurance - noncurrent
Cash held in Trust Account
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accounts payable
Accrued expenses
Promissory note - related party
Accrued offering costs
Accrued contingent legal costs
Due to Sponsor
Promissory notes - related party
Derivative liability - promissory note - related party redemption feature
Convertible promissory notes - related party
Class A ordinary shares tendered for redemption (7,996,024 ordinary shares)
Total current liabilities
Warrant liabilities
Deferred underwriting fee payable
TOTAL LIABILITIES
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption; 5,181,909 and 13,177,933 shares at redemption value of $11.16 per share and $10.77 per share at June 30, 2024 and December 31, 2023, respectively
Shareholders’ Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Common Stock, Value, Issued
Class A Ordinary Shares
Class B Ordinary Shares
Common Class B
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support